Sign Out
Safe use of Clarityn-D 24Hour Extended Release during pregnancy has not been established. Therefore, it should be used only if the potential benefit justifies the potential risk to the fetus.
Since loratadine and pseudoephedrine sulfate are excreted in breast milk, a decision should be made whether to discontinue nursing or to discontinue the use of Clarityn-D 24Hour Extended Release.
